Finance

Lists
1228:HKG
Canbridge Pharmaceuticals Inc
HK$1.84
-1.34%
(-0.025) 1D
Sep 8, 4:00:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1228...
Open
HK$1.89
High
HK$1.91
Low
HK$1.83
Mkt. cap
938.09M
Avg. vol.
0.00
Volume
331.00K
52-wk high
HK$3.50
52-wk low
HK$1.61
Shares outstanding
8.19B
No. of employees
39
Open
HK$1.89
High
HK$1.91
Low
HK$1.83
Mkt. cap
938.09M
Avg. vol.
0.00
Volume
331.00K
52-wk high
HK$3.50
52-wk low
HK$1.61
Shares outstanding
8.19B
No. of employees
39
About Canbridge Pharmaceuticals Inc
CEO-
Employees39
Founded2012
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
13.87M
13.87M
13.97M
13.97M
Cost of goods sold
2.92M
2.92M
4.64M
4.64M
Cost of revenue
2.92M
2.92M
4.64M
4.64M
Research and development expenses
13.53M
13.53M
6.25M
6.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.45M
22.45M
27.12M
27.12M
Operating expense
35.98M
35.98M
33.37M
33.37M
Total operating expenses
38.90M
38.90M
38.01M
38.01M
Operating income
-25.03M
-25.03M
-24.04M
-24.04M
Other non operating income
-965.50K
-965.50K
5.43M
5.43M
EBT including unusual items
-22.21M
-22.21M
-18.55M
-18.55M
EBT excluding unusual items
-21.92M
-21.92M
-18.54M
-18.54M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-22.21M
-22.21M
-18.55M
-18.55M
Net profit margin
-160.16%
-160.16%
-132.76%
-132.76%
Earnings per share
-
-
-
-
Interest and investment income
184.00K
184.00K
188.00K
188.00K
Interest expense
-230.50K
-230.50K
-124.50K
-124.50K
Net interest expenses
-46.50K
-46.50K
63.50K
63.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.32M
-22.32M
-21.31M
-21.31M
Gain or loss from assets sale
-78.50K
-78.50K
-
-
AI content may include mistakes. Learn more
Google apps